Advertisement

Topics

Corporate Communications, CEL-SCI Corporation Company Profile

05:37 EST 19th November 2017 | BioPortfolio

CEL-SCI Corporation (AMEX: CVM), a biotechnology company, was formed in 1983. CEL-SCI is involved in the research and development of drugs and vaccines for the treatment of cancer and infectious diseases. The Company’s core capabilities include drug discovery, research, development and manufacturing of complex biological substances.Recurrence of cancer is the greatest fear for the cancer patient and the treating physician. Wouldn’t it be great if we had an agent that could be used to enhance the success rate of the first cancer therapy? We think that our drug Multikine® is such an agent.Multikine is a combination, or "cocktail", of natural human interleukin-2 (IL-2) and certain lymphokines and cytokines (regulators of the immune system). In human testing Multikine has been shown to induce both an anti-cancer immune response and to significantly increase the susceptibility of the tumor cells to radiation therapy.

Location

8229 Boone Boulevard, Suite 802
Vienna
Virginia
22182
United States of America


News Articles [396 Associated News Articles listed on BioPortfolio]

Orion Corporation: Managers' transactions - Hilpi Rautelin

ORION CORPORATION      MANAGERS' TRANSACTIONS 1st of November 2017 at 22.15 EET              Orion Corporation: Managers' transactions - Hilpi Rautelin Orion Cor...

INSYS Therapeutics Hires First Corporate Communications Leader and New Investor Relations Agency

PHOENIX, Sept. 21, 2017 (GLOBE NEWSWIRE) -- Insys Therapeutics, Inc. (NASDAQ:INSY) ("INSYS" or "the Company"), today announced the hiring of Joe McGrath as the Company’s Senior Director of Corp...

CombiMatrix Corporation Reminds Shareholders to Vote "FOR" the Merger With Invitae Corporation

IRVINE, Calif., Nov. 02, 2017 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX) ("CombiMatrix" or the "Company"), a family health molecular diagnostics company specializing in DNA-based r...

CombiMatrix Corporation Stockholders Approve Merger Agreement With Invitae Corporation

IRVINE, Calif., Nov. 10, 2017 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX) ("CombiMatrix" or the "Company"), a family health molecular diagnostics company specializing in DNA-based r...

Hydropothecary appoints former BC Health Minister, Dr. Terry Lake, as VP of Corporate Social Responsibility

GATINEAU, QC--(Marketwired - August 31, 2017) - The Hydropothecary Corporation (TSX VENTURE: THCX) (the "Company" or "Hydropothecary") is pleased to announce the appointment of Dr. Terry Lake, DVM, t...

Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend CombiMatrix Corporation Shareholders Vote "FOR" the Proposed Merger with Invitae Corporation

IRVINE, Calif., Nov. 01, 2017 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX) ("CombiMatrix" or the "Company"), a family health molecular diagnostics company specializing in DNA-based r...

VWR Corporation to Report Third Quarter 2017 Results on November 7, 2017

RADNOR, Pa., October 26, 2017 -- VWR Corporation (NASDAQ: VWR), the leading global independent provider of product and service solutions to laboratory and production customers, today announce...

Prothena to Report Third Quarter 2017 Financial Results on November 7

DUBLIN, Ireland, Oct. 31, 2017 (GLOBE NEWSWIRE) -- Prothena Corporation plc (Nasdaq:PRTA), a late-stage clinical biotechnology company focused on the discovery, development and commercialization...

PubMed Articles [20 Associated PubMed Articles listed on BioPortfolio]

Communications of the median nerve in fetuses.

Communications between the median, ulnar and musculocutaneous nerves in the arm, forearm and hand were reported in adult cadaveric and electrophysiological studies. These communicant branches may lead...

Changes in prescribing and healthcare resource utilization after FDA Drug Safety Communications involving zolpidem-containing medications.

Products containing the sedative/hypnotic zolpidem were subject to Drug Safety Communications (DSCs) in January and May 2013 describing the risk of next-morning impairment and recommending lower start...

Communications.

XXXIX Reunion Anual de la Sociedad Andaluza de Neurologia. Communications (II).

XVI Reunion de la Sociedad Castellano-Manchega de Neurologia. Communications.

Clinical Trials [11 Associated Clinical Trials listed on BioPortfolio]

Multi-level Communications and Access Strategies to Improve the Food Environment

The overarching goal of B'More Healthy Retail Rewards (BHRR) is to develop, implement, and evaluate a pilot multi-level communications and pricing intervention to improve access to and con...

HERrespect Evaluation

This study evaluates whether a factory wide intervention, HERrespect, can reduce female garment workers' experiences of intimate partner violence, and experience and/or witnessing of viole...

Improving the Outpatient Referral Process With Electronic Communications

An electronic referral application will be developed and integrated into the existing outpatient information system. The primary goal of this software is to improve the quality and coordi...

The ACHIEVA Study of Enhanced Pharmacist Care on Antidepressant Use and Response

This a comparative study of enhanced pharmacist care and regular care of patients starting on antidepressants. When providing participants with enhanced care pharmacists will use the Healt...

Electronic Communications and Home Blood Pressure Monitoring

The control of blood pressure (BP) for patients with hypertension on medications has been elusive, despite the availability of evidence-based nationally recognized guidelines for treatment...

Companies [671 Associated Companies listed on BioPortfolio]

CANNINGS CORPORATE COMMUNICATIONS

Corporate Action Network

Corporate Action Network was founded to address the imbalance of power between corporations and people. Using the new tools of the Action Network and a networked approach, Corpora...

NEC Corporation of America

NEC Corporation of America (NEC) is a leading technology integrator providing solutions that improve the way people work and communicate. NEC delivers integrated Solutions for Soc...

Toshiba Corporation

Toshiba Medical Systems Corporation is a leading worldwide provider of medical diagnostic imaging systems and comprehensive medical solutions, such as CT, X-ray and vascular, ultr...

XO Communications

XO Communications provides the technology that helps business and wholesale customers compete in a hyper-connected economy. In the U.S., XO owns and operates one of the largest IP...

More Information about "Corporate Communications, CEL-SCI Corporation" on BioPortfolio

We have published hundreds of Corporate Communications, CEL-SCI Corporation news stories on BioPortfolio along with dozens of Corporate Communications, CEL-SCI Corporation Clinical Trials and PubMed Articles about Corporate Communications, CEL-SCI Corporation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Corporate Communications, CEL-SCI Corporation Companies in our database. You can also find out about relevant Corporate Communications, CEL-SCI Corporation Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...


Corporate Database Quicklinks



Searches Linking to this Company Record